lycopene/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases prostate cancer incidence
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“Participants in the highest quartile of lycopene intake displayed a significant 54% lower risk of prostate cancer compared to the lowest quartile (HR: 0.46; 95% CI: 0.23–0.95, p-trend = 0.035) in the fully adjusted model (Table 2, Fig. 1).”
Quoted verbatim from Lycopene intake and prostate cancer risk in men at high cardiovascular risk: a prospective cohort study.. - Study
- cohort
- Population
- Men aged 55-80 years at high cardiovascular risk from the PREDIMED trial; highest versus lowest quartile of cumulative dietary lycopene intake, fully adjusted model
Effect 0.46 hazard ratio, 95% CI 0.23 to 0.95
Lycopene intake and prostate cancer risk in men at high cardiovascular risk: a prospective cohort study.2025PMID:41214650Permalink
Keep reading
- Everything the graph holds on lycopene
- Every compound studied against Prostate cancer incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PD09CR3AMTVSWEPXZGSE48